Article | October 27, 2021

Steps to Consider For Implementing Continuous Bioprocessing

By Marc Bisschops, Senior Director, SLS - Integrated Process Solutions, Pall

Drug development iStock-1067499066

Now that continuous manufacturing is well established in small molecule circles, conversations have turned to continuous bioprocessing and bioprocess intensification. But some manufacturers are resistant to change. Here, Marc Bisschops, Senior Director, SLS - Integrated Process Solutions at Pall, explains why companies should be considering continuous for faster, more efficient routes to market.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online